How to Safely Stop Prolia (Denosumab): Discontinuation Protocol
A guide to safely discontinuing Prolia (denosumab), including bisphosphonate bridging protocols, rebound fracture risks, bone turnover monitoring, and step-by-step transition timelines.
Denosumab
15 source-based articles maintained by the HealthRX.com Editorial Team.
15articles
4topic areas covered
May 26, 2026latest review
Denosumab library
Showing 15 of 15 clinical reviews.
Late Prolia Injection: Catch-Up Dates, Fracture Evidence and Next Steps
A late Prolia dose resets the next six-month date. Use an injection-record worksheet and compare the actual delay and fracture evidence.
Prolia (Denosumab) Appetite & Cravings Changes: What the Evidence Actually Shows
Does Prolia (denosumab) affect appetite or cravings? A clinician-level review of the FREEDOM trial data, FDA adverse-event records, RANK/RANKL biology, and practical management steps for patients on denosumab.
Prolia (Denosumab) Cognitive Function Impact: What the Evidence Actually Shows
A deep-dive into denosumab (Prolia) and cognition: RANKL biology, FREEDOM trial data, pharmacovigilance signals, and clinical decision-making for patients concerned about brain fog or cognitive decline.
Prolia (Denosumab) Dosing in Renal Impairment: A Clinical Guide
Evidence-based guide to denosumab (Prolia) dosing in chronic kidney disease and dialysis, including mechanism, hypocalcemia risk, and discontinuation considerations, for clinician and patient education. Pending qualified medical review.
Prolia (Denosumab) Food & Supplement Interactions
A guide to denosumab food and supplement interactions, covering calcium, vitamin D, magnesium, iron, and herbal agents that affect hypocalcemia risk, RANKL biology, and bone remodeling outcomes.
Prolia (Denosumab) Hair and Skin Changes: What Patients and Clinicians Need to Know
A clinical deep-dive into denosumab-associated dermatologic adverse effects, including eczema, cellulitis, alopecia, and rash, with primary-literature citations and practical management guidance.
Prolia (Denosumab) Mental Health and Mood Impact: What the Evidence Shows
A clinician-level review of denosumab (Prolia) and its effects on mental health, mood, depression, and neuropsychiatric symptoms. Includes trial data, mechanism analysis, and prescribing guidance.
Prolia (Denosumab) Monitoring Schedule: Labs & Exams
Complete monitoring schedule for Prolia (denosumab), including baseline labs, calcium checks, DEXA timing, and adverse-effect screening, with PubMed-cited evidence.
Prolia (Denosumab) Patent Status and Generic Timeline
A clinical review of the denosumab (Prolia/Xgeva) patent portfolio, biosimilar development pipeline, FDA regulatory pathway, and projected generic availability dates for patients and prescribers.
Prolia (Denosumab) Pre-Surgery Hold Window: What Clinicians Need to Know
A comprehensive clinical guide to the denosumab pre-surgery hold window, covering fracture rebound risk, optimal timing, bridging strategies, and evidence-based protocols for perioperative management of Prolia patients.
Prolia (Denosumab) Rebound Effects When Stopping: What Patients and Clinicians Need to Know
Stopping Prolia (denosumab) without a transition plan is associated with rapid bone loss and reports of multiple vertebral fractures within roughly a year. This guide explains the rebound mechanism, what the evidence does and does not establish, and the bridging decisions clinicians and patients face.
Prolia (Denosumab) Self-Injection Technique: What Patients Need to Know
Denosumab (Prolia) is administered by a healthcare provider every 6 months via subcutaneous injection. Learn about the injection process, whether self-administration is possible, proper technique, and what to expect during your appointment.
Prolia (Denosumab) Storage, Stability & Shelf Life: Complete Clinical Guide
Everything clinicians and patients need to know about denosumab (Prolia) storage temperatures, shelf life, stability data, cold-chain management, and what to do when a dose has been mishandled.
Prolia (Denosumab) Travel & Timezone-Shift Protocols
MD/PharmD-level guidance on managing denosumab injection timing during travel, timezone shifts, and international trips. Covers the 6-month dosing window, cold-chain requirements, and what to do if your Prolia shot is delayed.